Garmin Health partners with the University of Kansas Medical Center

By Catherine Sturman
Garmin, a global leader in wearable technology, and the University of Kansas Medical Center, a world-class academic medical research facility, have deci...

Garmin, a global leader in wearable technology, and the University of Kansas Medical Center, a world-class academic medical research facility, have decided to partner to foster innovation and better understand how wearables can assist in the detection and management of significant medical conditions. Their initial research will focus on sleep apnoea and atrial fibrillation.

The duo is working on multiple research projects, combining high-quality sensor data from Garmin devices, with the health care expertise of KU Medical Center researchers.

“Garmin Health is excited to work with a nationally-recognised institution like KU Medical Center that is on the forefront of digital health research,” explained Scott Burgett, Director of Garmin Health Engineering.

“As patients assume increased responsibility for their own health care, Garmin is committed to the development of wearables that can lead to the prevention or detection of serious health conditions. With long battery life, high water rating, and high-quality sensor data, we can provide meaningful features that will help reduce health care costs and provide useful functionality for everyday life.”

By continuing monitoring those with known conditions, healthcare professionals will gain essential insight and gain the ability to assist in delivering a well-informed course of treatment. KU Medical Center research provides clinically based data that can aid in the development of algorithms capable of identifying conditions such as sleep apnoea and atrial fibrillation.

See also

Sleep apnoea affects up to 18mn US citizens. Consequently, Garmin Health has worked with Suzanne Stevens, M.D., Clinical Assistant Professor of Neurology, and Catherine Siengsukon, Ph.D., Associate Professor of Physical Therapy and Rehabilitation Science, at KU Medical Center to study how wearables equipped with optical sensors could be used to detect sleep apnoea and provide a lower cost alternative to an overnight sleep centre evaluation.

Additionally, atrial fibrillation is the most common cardiac arrhythmia, increasing the risk of stroke by 500% and can cause heart failure. Affecting millions of people in the US, similarly to sleep apnoea, it is cumbersome and costly to detect.

“This research will help us better understand how wearables can do the same while asleep, helping to detect sleep apnoea, which left untreated can affect mood, memory, trigger heart arrhythmias, heart attacks, and even strokes,” commented Dr Stevens.

“Wearable technology capable of early detection and monitoring of heart rhythm disorders will be a revolutionary boon to cardiac care,” said Dr. Madhu Reddy, M.D., Associate Professor of Medicine at KU Medical Center and Division Director, Heart Rhythm Services in the Department of Cardiovascular Medicine at The University of Kansas Health System.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare